Third Harmonic Bio Inc. (THRD) NASDAQ

$9.44 (0.03) (-0.32%)

Market Cap: $385.57M

As of 03/28/24 04:00 PM EDT. Market closed.

(THRD)

Third Harmonic Bio Inc. (THRD)
NASDAQ

$9.44
(0.03) (-0.32%)

Market Cap: $385.57M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

third harmonic bio is a clinical-stage company developing a highly selective, oral kit inhibitor for treatment of severe allergy and inflammation. kit is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body’s interfaces with the external environment and that act as the key mediator of the inflammation ... read more

third harmonic bio is a clinical-stage company developing a highly selective, oral kit inhibitor for treatment of severe allergy and inflammation. kit is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body’s interfaces with the external environment and that act as the key mediator of the inflammation associated with allergic diseases. our lead product candidate, thb001, is the first highly selective, oral small-molecule kit inhibitor to enter clinical development. with promising drug-like properties and an encouraging early clinical profile, thb001 has the potential to revolutionize the treatment of a broad range of dermatologic, respiratory, and gastrointestinal allergic and mast-cell mediated inflammatory diseases. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Full Time Employees
26
URL
Address
.
PRICE CHART FOR THIRD HARMONIC BIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.49
Previous Close
$9.47
Days Range
$9.03 - $9.47
52 week range
$4.03 - $11.60
Volume
541,249
Avg. Volume (30 days)
130,312
Market Cap
$385.57M
Dividend Yield
-
P/E
-
Shares Outstanding
40,714,399
Open
$9.49
Previous Close
$9.47
Days Range
$9.03 - $9.47
52 week range
$4.03 - $11.60
Volume
541,249
Avg. Volume (30 days)
130,312
Market Cap
$385.57M
Dividend Yield
-
P/E
-
Shares Outstanding
40,714,399
FINANCIAL STATEMENTS FOR THIRD HARMONIC BIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR THIRD HARMONIC BIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Person JulieChief Administrative OfficerDec 05, 2023 Option Exercise$4.2012,86354,02512,863Dec 07, 2023, 04:04 PM
Person JulieChief Administrative OfficerDec 05, 2023 Sale$10.3012,863132,4840Dec 07, 2023, 04:04 PM
Conner Edward R.Chief Medical OfficerDec 05, 2023 Option Exercise$4.204,79020,1184,790Dec 07, 2023, 04:03 PM
Conner Edward R.Chief Medical OfficerDec 05, 2023 Sale$10.034,79048,0620Dec 07, 2023, 04:03 PM
BVF PARTNERS L P/IL10% OwnerDec 20, 2022 Buy$4.11214,063879,4992,332,638Dec 22, 2022, 06:49 PM
ORBIMED ADVISORS LLCDirectorSep 19, 2022 Buy$17.00300,0005,100,0005,779,071Sep 21, 2022, 06:00 PM
Bonita David PDirectorSep 19, 2022 Buy$17.00300,0005,100,0005,779,071Sep 21, 2022, 05:59 PM
Atlas Venture Fund XI, L.P.10% OwnerSep 19, 2022 Buy$17.00300,0005,100,00010,313,763Sep 19, 2022, 04:51 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Person JulieChief Administrative Officer12/05/202354,025
Person JulieChief Administrative Officer12/05/2023132,484
Conner Edward R.Chief Medical Officer12/05/202320,118
Conner Edward R.Chief Medical Officer12/05/202348,062
BVF PARTNERS L P/IL10% Owner12/20/2022879,499
ORBIMED ADVISORS LLCDirector09/19/20225,100,000
Bonita David PDirector09/19/20225,100,000
Atlas Venture Fund XI, L.P.10% Owner09/19/20225,100,000
FUNDS WITH A POSITION IN THIRD HARMONIC BIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC5,779,0711.27%No changeOther
RA CAPITAL MANAGEMENT, L.P.2,033,0560.35%111.37%Other
BLACKROCK INC.1,389,1780.00039%20.05%Other
GEODE CAPITAL MANAGEMENT, LLC400,6930.00046%10.95%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.152,0270.00345%-20.83%Other
UBS OCONNOR LLC64,7040.05%-48.24%Value
D. E. SHAW & CO., INC.26,7610.00026%NewOther
RENAISSANCE TECHNOLOGIES LLC13,0000.00022%NewOther
CHANGE IN SHARES OUTSTANDING FOR THIRD HARMONIC BIO INC
STOCK BUYBACKS FOR THIRD HARMONIC BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.48%
1Q
12/31/2023
06/30/2023
0.78%
2Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.48%
1Q
06/30/2023
0.78%
2Q
BUYBACK ANNOUNCEMENT(S) FOR THIRD HARMONIC BIO INC
LOADING...